Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.575
-0.025 (-0.96%)
Aug 11, 2026, 3:44 PM EDT - Market open
Cellectar Biosciences Employees
Cellectar Biosciences had 11 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,894,632
Market Cap
20.58M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | 0 | - |
| Dec 31, 2024 | 11 | -9 | -45.00% |
| Dec 31, 2023 | 20 | 5 | 33.33% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Dec 31, 2021 | 12 | 1 | 9.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 115 |
| Daré Bioscience | 24 |
| Citius Pharmaceuticals | 23 |
| Quantum BioPharma | 17 |
| Atossa Therapeutics | 16 |
| Cocrystal Pharma | 10 |
| Neuphoria Therapeutics | 8 |
CLRB News
- 12 days ago - Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026 - GlobeNewsWire
- 27 days ago - Cellectar Biosciences publishes iopofosine I 131 dose-escalation study results - TheFly
- 27 days ago - Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers - GlobeNewsWire
- 4 weeks ago - Cellectar Biosciences initiated with a Buy at Brookline - TheFly
- 2 months ago - Cellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual Meeting - GlobeNewsWire
- 2 months ago - Cellectar Biosciences Slides: Corporate presentation - Filings
- 2 months ago - Cellectar Biosciences Registration statement: Registration filing - Filings
- 2 months ago - Cellectar Biosciences Proxy statement: Proxy filing - Filings